Document is current
Any future updates will be listed below
-
Authors
Cocozza, Sirio
Cosottini, Mirco
Signori, Alessio
Fleysher, Lazar
El Mendili, Mohamed Mounir
Lublin, Fred
Inglese, Matilde
Roccatagliata, Luca
-
Funding
Funding for this research was provided by:
Teva Pharmaceutical Industries (CNS-2014-221)
- License Information
-
More Information
Article History
Received: 9 January 2020
Revised: 25 February 2020
Accepted: 11 March 2020
First Online: 24 March 2020
Compliance with ethical standards
:
: The scientific guarantor of this publication is Matilde Inglese.
: The authors of this manuscript declare relationships with the following companies:SC received fees for speaking from Genzyme and Shire.MI is co-editor for Controversies of Multiple Sclerosis Journal. Received research grants from NIH, NMSS, FISM, and TEVA Neuroscience, and fees for consulting from Roche, Biogen, Merk, and Genzyme.
: Alessio Signori kindly provided statistical advice for this manuscript. One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: • Prospective• Observational• Performed at one institution
